Related Experiment Videos

Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphoma

L A VanderMolen¹, R G Steis, P L Duffey

¹Division of Cancer Treatment, National Cancer Institute, NCI Frederick Cancer.

Journal of the National Cancer Institute

|February 7, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A crown-group cnidarian from the Ediacaran of Charnwood Forest, UK.

Nature ecology & evolution·2022

Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer.

British journal of cancer·2014

Merging of Landau levels in a strongly interacting two-dimensional electron system in silicon.

Physical review letters·2014

Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

See all related articles